For a patient with metastatic castration-resistant prostate cancer to the bones with rising PSA but no evidence of radiographic or symptomatic progression, would you continue with the same treatment or change therapy based on biochemical progression?
Assuming there was an initial period of response to the mCRPC treatment.
I would reply to the comment "radiographic progres...